Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-normal saline versus albumin-gelatin fluid therapy after liver transplant surgery
IRCT20141009019470N88Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of albumin (human), gelatin and Normal Saline-Benha University in hepatic disease (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Glomerular filtration rate, Serum creatinine level and 3 more. Started Sep 2019; status: completed.
02
Drugs
albumin (human)gelatinNormal Saline-Benha University
03
Conditions
hepatic disease
Beyond the preview
Go deeper on IRCT20141009019470N88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N88.